Literature DB >> 23827825

Mutational analysis of the 5' non-coding region of GJB1 in a Taiwanese cohort with Charcot-Marie-Tooth neuropathy.

Pei-Chien Tsai1, Chung-Huang Chen, An-Bon Liu, Yun-Chung Chen, Bing-Wen Soong, Kon-Ping Lin, Shaw-Fang Yet, Yi-Chung Lee.   

Abstract

Mutations in the 5' non-coding region of GJB1 are rarely reported in patients with Charcot-Marie-Tooth disease (CMT). We therefore aimed to assess the frequency and identities of the GJB1 5' non-coding region mutations in a cohort of CMT. We analyzed the 5' non-coding region of GJB1 (including the promoter P2 and exon 1b) in 91 unrelated CMT patients without an identified genetic cause. Two mutations, c.-529T>C, and c.-459C>T, were identified in one patient each. One polymorphism, c.-713G>A, was also identified in 53 patients and 73 of the 100 control subjects. The luciferase reporter assays showed that c.-459C>T significantly reduced the luciferase expression with or without SOX10 activation, whereas c.-529T>C impaired the expression only with SOX10 co-expression. c.-713G>A had no apparent functional effect. Mutations in the 5' non-coding region of GJB1 account for 0.8% (2 of 251) of CMT and 2.2% (2 of 91) of genetically unassigned CMT in a Taiwanese cohort. As previously demonstrated, c.-459C>T and c.-529T>C may cause CMT through compromising GJB1 expression whereas c.-713G>A is a benign variant. This study highlights the pathogenic role of the GJB1 5' non-coding region mutations in CMT, and suggests that their identification should be considered for CMT patients without commonly observed mutations.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5′ non-coding region; CMT; CX32; Charcot–Marie–Tooth disease; GJB1; HMSN; Promoter

Mesh:

Substances:

Year:  2013        PMID: 23827825     DOI: 10.1016/j.jns.2013.06.011

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

2.  Establishing and validating regulatory regions for variant annotation and expression analysis.

Authors:  Alexander Kaplun; Mathias Krull; Karthick Lakshman; Volker Matys; Birgit Lewicki; Jennifer D Hogan
Journal:  BMC Genomics       Date:  2016-06-23       Impact factor: 3.969

3.  Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT.

Authors:  Pedro J Tomaselli; Alexander M Rossor; Alejandro Horga; Zane Jaunmuktane; Aisling Carr; Paola Saveri; Giuseppe Piscosquito; Davide Pareyson; Matilde Laura; Julian C Blake; Roy Poh; James Polke; Henry Houlden; Mary M Reilly
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

4.  Mutation spectrum of Charcot-Marie-Tooth disease among the Han Chinese in Taiwan.

Authors:  Yun-Hsin Hsu; Kon-Ping Lin; Yuh-Cherng Guo; Yu-Shuen Tsai; Yi-Chu Liao; Yi-Chung Lee
Journal:  Ann Clin Transl Neurol       Date:  2019-05-27       Impact factor: 4.511

5.  Revisiting the pathogenic mechanism of the GJB1 5' UTR c.-103C > T mutation causing CMTX1.

Authors:  Bianca R Grosz; John Svaren; Gonzalo Perez-Siles; Garth A Nicholson; Marina L Kennerson
Journal:  Neurogenetics       Date:  2021-06-05       Impact factor: 2.660

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.